These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 29049331)

  • 1. HIV dynamics linked to memory CD4+ T cell homeostasis.
    Murray JM; Zaunders J; Emery S; Cooper DA; Hey-Nguyen WJ; Koelsch KK; Kelleher AD
    PLoS One; 2017; 12(10):e0186101. PubMed ID: 29049331
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV DNA subspecies persist in both activated and resting memory CD4+ T cells during antiretroviral therapy.
    Murray JM; Zaunders JJ; McBride KL; Xu Y; Bailey M; Suzuki K; Cooper DA; Emery S; Kelleher AD; Koelsch KK;
    J Virol; 2014 Mar; 88(6):3516-26. PubMed ID: 24403590
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Integrated HIV DNA accumulates prior to treatment while episomal HIV DNA records ongoing transmission afterwards.
    Murray JM; McBride K; Boesecke C; Bailey M; Amin J; Suzuki K; Baker D; Zaunders JJ; Emery S; Cooper DA; Koelsch KK; Kelleher AD;
    AIDS; 2012 Mar; 26(5):543-50. PubMed ID: 22410637
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Early antiretroviral therapy with raltegravir generates sustained reductions in HIV reservoirs but not lower T-cell activation levels.
    Hey-Cunningham WJ; Murray JM; Natarajan V; Amin J; Moore CL; Emery S; Cooper DA; Zaunders J; Kelleher AD; Koelsch KK;
    AIDS; 2015 May; 29(8):911-9. PubMed ID: 25730509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Potential of integrase inhibitors to deplete HIV reservoirs or prevent their replenishment].
    Llibre JM; Martínez-Picado J
    Enferm Infecc Microbiol Clin; 2008 Nov; 26 Suppl 12():17-22. PubMed ID: 19572421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Episomal HIV-1 DNA and its relationship to other markers of HIV-1 persistence.
    Martinez-Picado J; Zurakowski R; Buzón MJ; Stevenson M
    Retrovirology; 2018 Jan; 15(1):15. PubMed ID: 29378611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of intensification with raltegravir on the HIV-1 reservoir of latently infected memory CD4 T cells in suppressed patients.
    Vallejo A; Gutierrez C; Hernandez-Novoa B; Diaz L; Madrid N; Abad-Fernandez M; Dronda F; Perez-Elias MJ; Zamora J; Muñoz E; Muñoz-Fernandez MA; Moreno S
    AIDS; 2012 Sep; 26(15):1885-94. PubMed ID: 22992577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamics of CD8 T-cell activation after discontinuation of HIV treatment intensification.
    Massanella M; Esteve A; Buzón MJ; Llibre JM; Puertas MC; Gatell JM; Domingo P; Stevenson M; Clotet B; Martinez-Picado J; Blanco J;
    J Acquir Immune Defic Syndr; 2013 Jun; 63(2):152-60. PubMed ID: 23392458
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
    Pierson T; McArthur J; Siliciano RF
    Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased homeostatic cytokines and stability of HIV-infected memory CD4 T-cells identify individuals with suboptimal CD4 T-cell recovery on-ART.
    Pino M; Pereira Ribeiro S; Pagliuzza A; Ghneim K; Khan A; Ryan E; Harper JL; King CT; Welbourn S; Micci L; Aldrete S; Delman KA; Stuart T; Lowe M; Brenchley JM; Derdeyn CA; Easley K; Sekaly RP; Chomont N; Paiardini M; Marconi VC
    PLoS Pathog; 2021 Aug; 17(8):e1009825. PubMed ID: 34449812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Virologic and immunologic effects of adding maraviroc to suppressive antiretroviral therapy in individuals with suboptimal CD4+ T-cell recovery.
    Cillo AR; Hilldorfer BB; Lalama CM; McKinnon JE; Coombs RW; Tenorio AR; Fox L; Gandhi RT; Ribaudo H; Currier JS; Gulick RM; Wilkin TJ; Mellors JW
    AIDS; 2015 Oct; 29(16):2121-9. PubMed ID: 26544577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Impaired Th17 polarization of phenotypically naive CD4(+) T-cells during chronic HIV-1 infection and potential restoration with early ART.
    DaFonseca S; Niessl J; Pouvreau S; Wacleche VS; Gosselin A; Cleret-Buhot A; Bernard N; Tremblay C; Jenabian MA; Routy JP; Ancuta P
    Retrovirology; 2015 Apr; 12():38. PubMed ID: 25924895
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lack of concordance between residual viremia and viral variants driving de novo infection of CD4(+) T cells on ART.
    Puertas MC; Noguera-Julian M; Massanella M; Pou C; Buzon MJ; Clotet B; Stevenson M; Paredes R; Blanco J; Martinez-Picado J
    Retrovirology; 2016 Aug; 13(1):51. PubMed ID: 27484989
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Five years' real-life experience with raltegravir in a large HIV centre.
    van Halsema C; Whitfield T; Lin N; Ashton K; Torkington A; Ustianowski A
    Int J STD AIDS; 2016 Apr; 27(5):387-93. PubMed ID: 25931236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment with integrase inhibitor suggests a new interpretation of HIV RNA decay curves that reveals a subset of cells with slow integration.
    Cardozo EF; Andrade A; Mellors JW; Kuritzkes DR; Perelson AS; Ribeiro RM
    PLoS Pathog; 2017 Jul; 13(7):e1006478. PubMed ID: 28678879
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Treatment intensification followed by interleukin-7 reactivates HIV without reducing total HIV DNA: a randomized trial.
    Katlama C; Lambert-Niclot S; Assoumou L; Papagno L; Lecardonnel F; Zoorob R; Tambussi G; Clotet B; Youle M; Achenbach CJ; Murphy RL; Calvez V; Costagliola D; Autran B;
    AIDS; 2016 Jan; 30(2):221-30. PubMed ID: 26684819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Different plasma markers of inflammation are influenced by immune recovery and cART composition or intensification in treated HIV infected individuals.
    Massanella M; Ouchi D; Marfil S; Llibre JM; Puertas MC; Buzón MJ; Richman DD; Orna E; Stevenson M; Gatell JM; Domingo P; Negredo E; Martinez-Picado J; Clotet B; Blanco J
    PLoS One; 2014; 9(12):e114142. PubMed ID: 25462535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The forces driving clonal expansion of the HIV-1 latent reservoir.
    Liu R; Simonetti FR; Ho YC
    Virol J; 2020 Jan; 17(1):4. PubMed ID: 31910871
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of raltegravir intensification on viral load and 2-LTR dynamics in HIV patients on suppressive antiretroviral therapy.
    Wang X; Mink G; Lin D; Song X; Rong L
    J Theor Biol; 2017 Mar; 416():16-27. PubMed ID: 28025011
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Quantification of latent tissue reservoirs and total body viral load in HIV-1 infection.
    Chun TW; Carruth L; Finzi D; Shen X; DiGiuseppe JA; Taylor H; Hermankova M; Chadwick K; Margolick J; Quinn TC; Kuo YH; Brookmeyer R; Zeiger MA; Barditch-Crovo P; Siliciano RF
    Nature; 1997 May; 387(6629):183-8. PubMed ID: 9144289
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.